U.S. Markets closed

DIAGNOS Inc. (ADK.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.5600-0.0100 (-1.75%)
At close: 3:52PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5700
Open0.5700
Bid0.5500 x 0
Ask0.5600 x 0
Day's Range0.5600 - 0.5700
52 Week Range0.1400 - 0.7700
Volume19,651
Avg. Volume106,974
Market Cap37.69M
Beta (5Y Monthly)0.35
PE Ratio (TTM)N/A
EPS (TTM)-0.0330
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.95
  • DIAGNOS Announces the Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia
    GlobeNewswire

    DIAGNOS Announces the Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia

    Magrabi Hospital Magrabi Hospitals launches initiative for early screening for diabetic retinopathy BROSSARD, Quebec, July 22, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the official opening of the initial clinics at the Magrabi Hospital. Dr. Ibrahim Al-Omar, Undersecretary of the Ministry of Health for Investment, inaugurated last Wednesday the ear

  • DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE
    GlobeNewswire

    DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE

    BROSSARD, Quebec, July 20, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the initiation of a clinical trial study with CommonSpirit Health Research Institute, Chattanooga Center for Neurologic Research LLC and conducted at the CommonSpirit Hospital in Chattanooga, to confirm early Proof-of-Concept results that showed a strong potential in the early detection of stroke th

  • DIAGNOS Announces a Pilot with Hospital Oftalmológico Buena Vista Sinaloa
    GlobeNewswire

    DIAGNOS Announces a Pilot with Hospital Oftalmológico Buena Vista Sinaloa

    BROSSARD, Quebec, June 15, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the signing of a 2-month pilot with Hospital Oftalmológico Buena Vista Sinaloa, the largest ophthalmological hospital in Sinaloa State, Mexico. In Mexico there are 18 million diabetics with a 23% prevalence in people of 20 years or more; the seriousness of these cases is that every hour in the c